Literature DB >> 12534743

Immunological findings in acute and chronic pancreatitis.

Archana Bhatnagar1, Jai Dev Wig, Siddartha Majumdar.   

Abstract

BACKGROUND: In order to identify the role of mononuclear cells in pancreatitis, the immune picture at the cellular level has been studied. The cytokine production at the individual cell level in response to in vitro stimulation can help in identifying the percentage of specific cell types producing a particular cytokine.
METHODS: A total of 30 patients with acute pancreatitis (AP; n = 15) and chronic pancreatitis (CP; n = 15) were entered into the study and peripheral blood samples were drawn at the time of admission. A control group of 12 healthy individuals (age and sex matched) were also included in the study. Mononuclear cells from the peripheral blood from all three groups were separated on Ficoll gradient and labelled for surface antigens (i.e. cluster of differentiation (CD)3, CD4, CD8, CD25, CD14 and human leucocyte antigen D receptor (HLA-DR)) using monoclonal antibodies. The CD3+ and CD14+ cells were also stained for intracellular cytokines by specific monoclonal antibodies (i.e. for interferon (IFN)-gamma, interleukin (IL)-2, IL-4 & IL-10 in CD3+ cells and IL-6 and IL-12 in CD14+ cells). These fluorochrome-labelled cells were analysed on the flow cytometer.
RESULTS: The T-cell population is affected in pancreatitis where the CD4+ and CD8+ T-cell numbers are significantly altered. There is a marked reduction in CD4+ T cells in AP and CP. The CD8+ T cells were significantly reduced in AP. The IL-2 receptor is expressed in large numbers in AP and CP patient groups. The T cells from the CP group had a typical IL-2, IL-4 secreting pattern, while AP patients had a high IL-10, IFN-gamma and low IL-2, IL-4 population. The HLA-DR expression on monocytes differed significantly between the two groups, being strikingly reduced in chronic cases and significantly reduced in acute cases. The percentage of IL-6-producing monocytes was significantly higher in patients with AP as well as CP while IL-12 levels were higher in the CP than in the AP group.
CONCLUSIONS: T cells in CP are polarized towards the T-helper (Th)1 phenotype while the AP patients had a mixed population. This seems to be a part of immune deviation that is associated with development of CP and IL-12 appears to be instrumental in this process. The monocytes synthesize proinflammatory cytokines, which play an important role in the local and systemic consequences of the disease. In the disease clinical assessment such a study can provide useful information about the involvement of the immuno-inflammatory system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12534743     DOI: 10.1046/j.1445-2197.2003.02621.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  10 in total

1.  Differences in platelet endothelial cell adhesion molecule-1 expression between peripheral circulation and pancreatic microcirculation in cerulein-induced acute edematous pancreatitis.

Authors:  Hong-Kai Gao; Zong-Guang Zhou; Fang-Hai Han; You-Qin Chen; Wen-Wei Yan; Tao He; Cun Wang; Zhao Wang
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

2.  Evaluating the Immunopathogenesis of Diabetes After Acute Pancreatitis in the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: From the Type 1 Diabetes in Acute Pancreatitis Consortium.

Authors:  Anna Casu; Paul J Grippo; Clive Wasserfall; Zhaoli Sun; Peter S Linsley; Jessica A Hamerman; Brian T Fife; Adam Lacy-Hulbert; Frederico G S Toledo; Phil A Hart; Georgios I Papachristou; Melena D Bellin; Dhiraj Yadav; Maren R Laughlin; Mark O Goodarzi; Cate Speake
Journal:  Pancreas       Date:  2022-07-01       Impact factor: 3.243

Review 3.  Severe acute pancreatitis: Clinical course and management.

Authors:  Hans G Beger; Bettina M Rau
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

4.  Clinical significance of interleukin-6 (IL-6) gene polymorphism and IL-6 serum level in pancreatic adenocarcinoma and chronic pancreatitis.

Authors:  Renata Talar-Wojnarowska; Anita Gasiorowska; Beata Smolarz; Hanna Romanowicz-Makowska; Andrzej Kulig; Ewa Malecka-Panas
Journal:  Dig Dis Sci       Date:  2008-07-26       Impact factor: 3.199

Review 5.  Complex role for the immune system in initiation and progression of pancreatic cancer.

Authors:  Kristin S Inman; Amanda A Francis; Nicole R Murray
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

6.  Interleukin-18, together with interleukin-12, induces severe acute pancreatitis in obese but not in nonobese leptin-deficient mice.

Authors:  Joseph A Sennello; Raja Fayad; Maria Pini; Melissa E Gove; Venkatesh Ponemone; Robert J Cabay; Britta Siegmund; Charles A Dinarello; Giamila Fantuzzi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-30       Impact factor: 11.205

7.  Primary culture of pancreatic (human) acinar cells.

Authors:  Lipi Singh; Dapinder K Bakshi; Rakesh Kumar Vasishta; Sunil Kumar Arora; Siddarth Majumdar; Jai Dev Wig
Journal:  Dig Dis Sci       Date:  2008-02-02       Impact factor: 3.199

8.  Bach2 repression mediates Th17 cell induced inflammation and associates with clinical features of advanced disease in chronic pancreatitis.

Authors:  M Sasikala; V V Ravikanth; K Murali Manohar; Neha Deshpande; Sandhya Singh; P Pavan Kumar; R Talukdar; Sudip Ghosh; Mohsin Aslam; G V Rao; R Pradeep; D Nageshwar Reddy
Journal:  United European Gastroenterol J       Date:  2017-06-20       Impact factor: 4.623

Review 9.  The Critical Role of Bach2 in Shaping the Balance between CD4+ T Cell Subsets in Immune-Mediated Diseases.

Authors:  Lingyi Yang; Shuli Chen; Qiuyu Zhao; Ying Sun; Hong Nie
Journal:  Mediators Inflamm       Date:  2019-12-30       Impact factor: 4.711

Review 10.  Mechanisms of Post-Pancreatitis Diabetes Mellitus and Cystic Fibrosis-Related Diabetes: A Review of Preclinical Studies.

Authors:  Eleonóra Gál; Jurij Dolenšek; Andraž Stožer; László Czakó; Attila Ébert; Viktória Venglovecz
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-10       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.